Investments and Business

The United States and China have once again extended a trade truce, delaying a potential escalation of tariffs that would have significantly disrupted the global economy. In an executive order signed just hours before the previous agreement was set to expire, President Donald Trump postponed the imposition of higher tariffs on Chinese imports for an additional 90 days. This decision, which Beijing reciprocated with a parallel extension, provides both nations with more time to address their ongoing trade disputes and work toward a more comprehensive agreement. The move was widely seen as a necessary step to prevent a full-blown trade…

The escalating public dispute between Elon Musk, Apple, and OpenAI has reached a new level of intensity, fueled by accusations and legal threats. Musk, the owner of X and founder of the AI company xAI, has publicly accused Apple of engaging in what he calls "unequivocal antitrust violation" by allegedly favoring OpenAI's ChatGPT in its App Store. He threatened to take immediate legal action against the tech giant. This bold claim came in a series of posts on his social media platform, where he also directly challenged OpenAI CEO Sam Altman, calling him a "liar" and reigniting their long-standing animosity.…

The world's largest publicly listed company, famous for its tech advancements and international influence, has surprisingly become embroiled in one of the most prominent international tensions of the past few years. What started as a commercial conflict between the United States and China transformed into a wider political clash during the Trump administration, bringing this corporate titan into a challenging and volatile situation.Although large companies frequently conduct business internationally and manage intricate dealings with various governments, the potential consequences in this scenario were notably significant. This organization’s extensive network of suppliers spans multiple continents, heavily depending on Chinese production for…

Former President of the United States, Donald Trump, is once more in the spotlight following a daring promise: to reduce prescription drug costs by an incredible 1,500%. This statement has stirred enthusiasm among his followers and ignited discussions across various political arenas. However, the magnitude of the figure has prompted numerous experts, commentators, and regular citizens to ponder over the feasibility, mathematical validity, and potential implementation of such a proposal.At first glance, the claim grabs attention. The cost of medications has been a continuous concern for countless people in the United States, impacting not only those requiring treatment but also…